ABBV-151

ABBV-151 is a humanized monoclonal antibody inhibitor of GARP- TGF-β1 being investigated for the treatment of cancer.

 

Type of Molecule

Biologic

Target

GARP-TGF-β1

Product Type

New Indication
Potential Indication Region Phase (1, 2, 3, Submitted, Approved)
Solid Tumors n/a
Phase 1